The quest for biomarker discovery in pulmonary arterial hypertension: the right takes lessons from the left
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Funding This work was supported by National Institutes of Health (K08HL111207-01A1), American Heart Association (AHA 15GRNT25080016), Cardiovascular Medical Research and Education Foundation (CMREF) and the Klarman Foundation (Boston, Massachusetts, USA) at Brigham and Women's Hospital.
Competing interests BAM receives funding from Gilead Sciences Inc. to study pulmonary hypertension.
Provenance and peer review Commissioned; internally peer reviewed.